Skip to main content
Livermore
Livermore
ZHEN

Glen Eagle Advisors, LLC

SEC CIK
0002029317
Latest filing
Aug 14, 2026

NVO holding history

Novo Nordisk A S in every 13F filed by Glen Eagle Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NVO overviewAll 13F holders of NVOFull Q2 2026 holdings

Shares (Q2 2026)
953
Value
$45.7K
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of NVO by Glen Eagle Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026953$45.7K<0.1%−226−19.2%ReducedHolders
Q1 20261,179$43.3K<0.1%−265−18.4%ReducedHolders
Q4 20251,444$73.5K<0.1%−758−34.4%ReducedHolders
Q3 20252,202$122.2K<0.1%−3,492−61.3%ReducedHolders
Q2 20255,694$393.0K0.1%−1,625−22.2%ReducedHolders
Q1 20257,319$508.3K0.1%−4,149−36.2%ReducedHolders
Q4 202411,468$986.5K0.2%−260−2.2%ReducedHolders
Q3 202411,728$1.40M0.2%+1,103+10.4%AddedHolders
Q2 202410,625$1.52M0.3%+1,591+17.6%AddedHolders
Q1 20249,034$1.16M0.2%+1,281+16.5%AddedHolders
Q4 20237,753$802.1K0.2%−3,726−32.5%ReducedHolders
Q3 202311,479$1.04M0.2%+9,105+383.5%AddedConverted for a 2-for-1 splitHolders
Q2 20231,187$191.9K<0.1%+1,166+5,552.4%AddedHolders
Q1 202321$3.34K<0.1%−2−8.7%ReducedHolders
Q4 202223$3.11K<0.1%+23NewHolders
Q2 20220$00.0%−13−100.0%Sold outHolders
Q1 202213$1.44K<0.1%−100−88.5%ReducedHolders
Q4 2021113$12.7K<0.1%−387−77.4%ReducedHolders
Q3 2021500$48.0K<0.1%00.0%UnchangedHolders
Q2 2021500$41.9K<0.1%00.0%UnchangedHolders
Q1 2021500$33.7K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.